Nasenspray Erwachsene (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasenspray Erwachsene, is an imidazoline derivative presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults. GNH USA supplies Nasenspray Erwachsene as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride is used as a topical nasal decongestant to reduce swelling of the nasal mucosa in several common conditions.

Common cold: alleviates nasal blockage caused by viral upper‑respiratory infection. Sinusitis: reduces mucosal edema to improve sinus drainage. Allergic rhinitis: diminishes congestion due to allergen‑induced inflammation.

Xylometazoline Hydrochloride may cause local and systemic reactions, most of which are mild and transient.

Common Side Effects: - Nasal burning or stinging sensation. - Mild nasal dryness. - Sneezing shortly after application. - Headache. - Temporary taste alteration. - Mild epistaxis (nosebleed).

Serious or Rare Side Effects: - Persistent hypertension. - Severe nasal ulceration. - Rebound congestion with prolonged use. - Allergic rash or angioedema. - Cardiac palpitations. - Vision changes.

Before using Nasenspray Erwachsene, consider the following safety measures.

Avoid prolonged use: limit to 3‑5 days to prevent rebound congestion. Pregnancy and lactation: consult a healthcare professional before use. Cardiovascular disease: use with caution in patients with hypertension or heart disease. Drug interactions: inform the prescriber of any concurrent nasal or systemic decongestants. Children and adolescents: not recommended for individuals under 12 years. Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with other agents that affect blood pressure or nasal vasoconstriction.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive effects. - Other topical nasal decongestants: increase risk of severe rebound congestion. - Systemic sympathomimetics: can cause additive cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive medications: monitor blood pressure for possible elevation. - Tricyclic antidepressants: observe for increased vasoconstrictive response. - Beta‑blockers: watch for altered heart rate or blood pressure changes.